Page 1 of Clinical Trials for ( Drug Lantus AND Amaryl ), 17 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
Last Updated: August 22, 2008
Condition(s): Diabetes Mellitus
2
Completed
Insulin Glargine Combination Therapies in Type II Diabetics
Last Updated: September 25, 2009
Condition(s): Diabetes Mellitus, Type 2
3
Completed
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
Last Updated: January 24, 2011
Condition(s): Type 2 Diabetes Mellitus
4
Completed
Insulin Glulisine in Type 2 Diabetic Patients
Last Updated: August 1, 2011
Condition(s): Diabetes Mellitus, Type 2
5
Completed
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
Last Updated: July 6, 2010
Condition(s): Diabetes Mellitus, Type 2
6
Recruiting
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Last Updated: June 2, 2009
Condition(s): Type 2 Diabetes Mellitus
7
Active, not recruiting
Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment
Last Updated: October 26, 2011
Condition(s): Diabetes Mellitus, Type 2
8
Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Last Updated: June 25, 2009
Condition(s): Diabetes Mellitus, Type 2
9
Completed
Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment
Last Updated: June 17, 2011
Condition(s): Diabetes Mellitus, Type 2
10
Completed
LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
Last Updated: August 8, 2011
Condition(s): Diabetes Mellitus Type II
11
Active, not recruiting
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-2)
Last Updated: May 24, 2012
Condition(s): Diabetes Mellitus, Type 2
12
Completed
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
Last Updated: May 13, 2009
Condition(s): Diabetes Mellitus, Type 2
13
Completed
Insulin Glargine During and After the Period of Fasting in Ramadan
Last Updated: June 7, 2011
Condition(s): Diabetes Mellitus, Type 2
14
Completed
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
Last Updated: February 2, 2011
Condition(s): Type 2 Diabetes Mellitus
15
Active, not recruiting
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
Last Updated: January 26, 2012
Condition(s): Type 2 Diabetes Mellitus; Pancreatic Beta Cell Function; Glucotoxicity
16
Recruiting
Short-Term Intensive Insulin Therapy Induction of Long-Term Glycemic Control
Last Updated: July 24, 2007
Condition(s): Type 2 Diabetes
17
Active, not recruiting
A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
Last Updated: March 4, 2008
Condition(s): Type 2 Diabetes Mellitus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Lantus%2C+Amaryl

Page 1 of Clinical Trials for ( Drug Lantus AND Amaryl ), 17 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About